Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

10.65 +0.78 (+7.90%)
Delayed Quote Updated: 3:50 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE
From Precision BioSciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Earnings Outlook For Precision BioSciences ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Precision BioSciences ↗
 
Via Benzinga
News headline image
Precision BioSciences to Present at Hep-DART 2023
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
Via ACCESSWIRE
News headline image
The Latest Analyst Ratings for Precision BioSciences ↗
 
Via Benzinga
News headline image
Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Present at Upcoming Sidoti Conference
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Announces Late-Breaking Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update
From Precision BioSciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Precision BioSciences to Report Third Quarter Results on November 7, 2023
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Present at Upcoming H.C. Wainwright 4th Annual Hepatitis B Virus Conference
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Receives U.S. Patent Allowance Covering PBGENE-PMM for m.3243-Associated Mitochondrial Diseases
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket ↗
Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment. 
Via Benzinga
News headline image
Precision BioSciences Hosts Virtual R&D Day Highlighting its Proprietary ARCUS Technology and Recent In Vivo Gene Editing Program Developments
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Attend and Present at Upcoming September Investor Conferences
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Host In Vivo Gene Editing R&D Day on September 12, 2023
From Precision BioSciences, Inc.
Via Business Wire
News headline image
What Is Precision BioSciences CAR T Pipeline Value? Analyst Lowers Price Target To Justify Valuation ↗
Wednesday, Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead... 
Via Benzinga
News headline image
Why Is Precision BioSciences Stock Soaring Today? ↗
Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead allogeneic... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Investors will want to get ready for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
News headline image
Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
From Precision BioSciences, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.